COMPANY
TEVA CANADA LIMITED
TEVA CANADA LIMITED: marketing authorisation holder for Daptomycin, Desmopressin, Icatibant, Octreotide, Teriparatide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Daptomycin | DAPTOMYCIN FOR INJECTION (DIN 02462117), Cancelled Pre Market Regulator Health Canada |
|---|---|
| Desmopressin | TEVA-DESMOPRESSIN (DIN 02287730), Cancelled Post Market Regulator Health Canada |
| Desmopressin | TEVA-DESMOPRESSIN (DIN 02287749), Cancelled Post Market Regulator Health Canada |
| Icatibant | TEVA-ICATIBANT (DIN 02513773), Cancelled Pre Market Regulator Health Canada |
| Octreotide | OCTREOTIDE FOR INJECTABLE SUSPENSION (DIN 02503751), Cancelled Post Market Regulator Health Canada |
| Octreotide | OCTREOTIDE FOR INJECTABLE SUSPENSION (DIN 02503778), Cancelled Post Market Regulator Health Canada |
| Octreotide | OCTREOTIDE FOR INJECTABLE SUSPENSION (DIN 02503786), Cancelled Post Market Regulator Health Canada |
| Octreotide | OCTREOTIDE INJECTION (DIN 02299429), Cancelled Post Market Regulator Health Canada |
| Octreotide | OCTREOTIDE INJECTION (DIN 02299437), Cancelled Post Market Regulator Health Canada |
| Octreotide | OCTREOTIDE INJECTION (DIN 02299445), Cancelled Post Market Regulator Health Canada |
| Octreotide | OCTREOTIDE INJECTION (DIN 02299453), Cancelled Post Market Regulator Health Canada |
| Teriparatide | TEVA-TERIPARATIDE INJECTION (DIN 02486423), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.